Second Avastin Trial Shows No Benefit in Early Stage Colon Cancer

Adding Avastin® (bevacizumab) to chemotherapy for early stage colon cancer didn’t reduce the risk that cancer would return. In fact, preliminary results of the AVANT trial found that chemotherapy alone worked better in preventing recurrences of stage III and high-risk stage II colon cancer, according to a news release from Roche, sponsors of the international clinical…  Read More

Afinitor Combined with Avastin Promises Help for Advanced Colorectal Cancer

Some colorectal cancer patients whose tumors had gotten worse on all standard treatments benefited from a combination of Afinitor® (everolimus) and Avastin® (bevacizumab) during a small trial reported at the 2010 ASCO Annual meeting in Chicago. While no tumors got smaller on the treatment, about half of patients in the Phase II trial had their cancer…  Read More

Avastin Helps Patients Maintain Chemotherapy Effectiveness

It doesn’t hurt to stop XELOX chemotherapy combined with Avastin after six treatments and continue with Avastin alone until colorectal cancer gets worse, according to a study reported at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago. Many patients have to stop oxaliplatin chemotherapy with before getting its maximum effectiveness because…  Read More

Continuing Avastin after Colorectal Cancer Gets Worse Increases Survival Time

Colorectal cancer patients benefited when they continued to include Avastin® (bevacizumab) in their chemotherapy plan after their cancer got worse after initial treatment. They lived longer after beginning a second round of chemotherapy with Avastin than did other patients who got chemo without Avastin or those who didn’t get any chemotherapy at all. The results are…  Read More

Colorectal Cancer News In Brief: December 4

Briefly: A video can help patients make personal decisions about end-of-life care.  Cancer death rates are falling in Europe, partly led by recent colorectal cancer declines. Avastin will now be covered for a longer time for people with advanced colorectal cancer in Ontario.  The Wellness Community in Valley/Ventura, California has a free workshop scheduled for December…  Read More

Avastin Effective for Older Patients

Colorectal cancer patients 65 and older without other serious medical problems benefitted when Avastin® (bevacizumab) was added to chemotherapy. Combining results of four randomized clinical trials of Avastin and chemotherapy in patients with advanced colorectal cancer, researchers found that adding Avastin increased both the time older patients lived and the time before their cancer got worse.…  Read More